Search       
Wednesday, August 20, 2008

Posters

Click to download pdf files

Quantification of a Polypeptide Drug, Desirudin, in Human PlasmaUsing Electrospray LC-MS/MS with an Analog Polypeptide as Internal Standard, Presented at The 56th ASMS Conference, Denver, CO, June 2008.

Comprehensive Investigation of Injection Time and Auto Gain Control on Ion Trap Instruments for LC/MS Application of Metabolite Identification, Presented at The 56th ASMS Conference, Denver, CO, June 2008.

A Rapid and High Sensitive LC-MS/MS Method for Quantitation of Budesonide in Human Plasma, Presented at The 56th ASMS Conference, Denver, CO, June 2008.

A Sensitive LC-MS/MS Method for Quantitation of Ribavirinin Human Plasma, Presented at The 56th ASMS Conference, Denver, CO, June 2008.

A High Sensitive LC-MS/MS Method for Quantitation of Formoterolin Human Plasma, Presented at The 56th ASMS Conference, Denver, CO, June 2008.

Automatic Generation of Extract ion Chromatogram for Mass Spectral Peaks with Specific Isotope Labeled Patterns, Presented at The 55th ASMS Conference, Indianapolis, IN, June 2007.

Mass Balance, Metabolism, and Excretion of Rambazole, a Novel Retinoic Acid Metabolism-Blocking Agent (RAMBA) in Mice, Rats, and Dogs, Presented at The 14th North American ISSX Meeting, Puerto Rico, October, 2006.

Sensitive and Rapid Method for the Determination of (R,R)-Formoterol and (S,S)-Formoterol in Human Plasma Using Chiral Liquid Chromatography-Tandem Mass Spectrometry, Presented at the 2006 AAPS Annual Meeting, San Antonio, TX, October 2006.

Determination of In Vivo Chiral Inversion of (R,R)-Formoterol to its Stereosiomers, (S,S)-Formoterol, (R,S)-Formoterol, and (S,R)-Formoterol, by Highly Sensitive and Specific LC/MS/MS Methods in Human Plasma Presented at the G., New England Drug Metabolism Discussion Group Summer Symposium, June, 2006.

LC/MS Chiral Methods and Its Application in Bioanalysis, Presented at The 54thASMS Conference, Seattle, WA, May 2006.

Reduction of nitriles to amines in positive ion electrospray ionization mass spectrometry, Presented in Rapid Communications in Mass Spectrometry, 20: 2969-2972, 2006.

A Highly Sensitive and Specific LC/MS/MS Method for Quantitation of Methotrexate and Its 7-Hydroxy Metabolite in Human Plasma, Presented at The 54th ASMS Conference, Seattle, WA, May 2006.

A New LC/MS/MS Method for Quantitation of Moxifloxacin in Human Plasma, Presented at the The 54th ASMS Conference, Seattle, WA, May 2006.

In Vitro Metabolism of 14C-Ciclesonide in Hepatocytes from Mice, Rats, Rabbits, Dogs and Humans
Presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, November, 2004, Baltimore MD.

Pharmacokinetics, Metabolism, and Excretion of Ciclesonide after Intravenous and Oral Administration of 14C-Ciclesonide in Mice, Rats, Rabbits and Dogs
Presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, November, 2004, Baltimore, MD.

Loss of Hydroxyl Radical (·OH) in CAD MD/MS for Identification of Oxidized Drug Metabolites
Presented at the American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, May, 2004, Nashville TN.

A Highly Sensitive and Specific LC/MS/MS Method (0.5 pg/mL) for Quantitation of (R,R)/(S,S)-Formoterol and (R,S)/(S,R)-Formoterol in Human Plasma and Urine
Presented at the American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, May, 2004, Nashville TN.

Tissue Distribution, Metabolism and Residue Depletion Study in Atlantic Salmon Following Oral Administration of 3H-SCH 58854
Presented at the International Society for the Study of XenoBiotics (ISSX) 12th North American Meeting, October, 2003, Providence, RI.

Determination of (R,R)-Formoterol Inversion Products in Human Plasma and Urine By Chiral and Achiral-LC/MS/MS
Presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October, 2003, Salt Lake City, UT.

Mass Balance Study of 14C-Nebivolol in Humans with Different CYP2D6 Genotypes
Presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October, 2003, Salt Lake City, UT.

Metabolism Study of 14C-Nebivolol in Humans with Different CYP2D6 Genotypes
Presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October, 2003, Salt Lake City, UT.

A Highly Sensitive and Specific LC/MS/MS Method (3 pg/mL) for Quantitation of Fluticasone Propionate in Human Plasma
Presented at the American Society for Mass Spectrometry (ASMS) 51st Conference on Mass Spectrometry, June, 2003, Montreal, QC.

Simultaneous Determination of the Enantiomers of Ketorolac as well as XBL011003 in Human Plasma with LC/MS
Presented at the American Society for Mass Spectrometry (ASMS) 51st Conference on Mass Spectrometry, June, 2003, Montreal, QC.

Simultaneous Quantitation of 9-Nitrocamptothecin an Anticancer Agent, and its Metabolite, 9-Aminocamptothecin by LC/MS/MS in Rat, Rabbit, and Human Plasma and Human Urine
Presented at the American Society for Mass Spectrometry (ASMS) 51st Conference on Mass Spectrometry, June, 2002, Orlando, FL.

A New Liquid Chromatography-Tandem Mass Spectrometry Method (0.1-1,000 ng/mL) for Quantitation of Paclitaxel in Human and Rat Plasma
Presented at the American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, June, 2002, Orlando, FL.

Formation of Metal Adduct Solvent Ions or Ion Clusters and the Influence on LC/MS Analysis
Presented at the American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry, June, 2002, Orlando, FL.